These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1037 related articles for article (PubMed ID: 19683330)
1. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors). Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330 [TBL] [Abstract][Full Text] [Related]
2. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734 [TBL] [Abstract][Full Text] [Related]
3. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis. Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression. Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859 [TBL] [Abstract][Full Text] [Related]
5. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Su MC; Hsu C; Kao HL; Jeng YM Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303 [TBL] [Abstract][Full Text] [Related]
6. Origin and pathological characteristics of Klatskin tumor: a case report and literature review. Somer L; Andrejić B; Milošević P Pol J Pathol; 2012 Mar; 63(1):65-70. PubMed ID: 22535609 [TBL] [Abstract][Full Text] [Related]
7. [Classification and staging systems for hilar cholangio-carcinoma (Klatskin tumors): clinical application and practical relevance]. Gavrilovici V; Grecu F; Seripcariu V; Dragomir C Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):412-7. PubMed ID: 21870733 [TBL] [Abstract][Full Text] [Related]
8. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma. Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893 [TBL] [Abstract][Full Text] [Related]
9. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma. Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639 [TBL] [Abstract][Full Text] [Related]
11. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282 [TBL] [Abstract][Full Text] [Related]
12. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642 [TBL] [Abstract][Full Text] [Related]
13. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma. Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797 [TBL] [Abstract][Full Text] [Related]
14. [Pathology of gallbladder and extrahepatic bile ducts. Case 6. Well- differentiated hilar cholangiocarcinoma pT2bN1]. Guettier C Ann Pathol; 2014 Aug; 34(4):309-14. PubMed ID: 25132442 [No Abstract] [Full Text] [Related]
15. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841 [TBL] [Abstract][Full Text] [Related]
16. [Surgical treatment of cholangiocellular carcinoma and proximal bile duct tumors]. Lorf T; Hanack U; Schwörer H; Sattler B; Ringe B Zentralbl Chir; 2000; 125(7):637-41. PubMed ID: 10960975 [TBL] [Abstract][Full Text] [Related]
17. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Masselli G; Gualdi G Abdom Imaging; 2008; 33(4):444-51. PubMed ID: 17638040 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges? Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969 [TBL] [Abstract][Full Text] [Related]
19. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma. Schmitz KJ; Lang H; Wohlschlaeger J; Reis H; Sotiropoulos GC; Schmid KW; Baba HA Virchows Arch; 2007 Feb; 450(2):135-41. PubMed ID: 17165088 [TBL] [Abstract][Full Text] [Related]
20. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]